Education
About Us
Working with TipRanks
Follow Us
Clinigence Holdings Inc (NUTX)
NASDAQ:NUTX
Earnings Data
Report Date
May 19, 2026TBA (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
3.99Last Year’s EPS
2.56Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a predominantly positive long‑term operational and financial story—very strong full‑year revenue growth (+82.4%), major margin and cash‑flow improvements, profitable and expanding IPAs, high patient satisfaction, and disciplined capital allocation. The principal negatives were a material, timing‑driven Q4 revenue/earnings hit from a CMS‑driven IDR true‑up and a large one‑time stock‑based compensation charge; these items created quarter volatility but appear to be nonrecurring or better understood by management. Given the substantial year‑over‑year improvements in revenue, adjusted EBITDA, cash flow and margins that outweigh the one‑time/quarterly headwinds and controllable operational initiatives underway, the overall sentiment is positive.Company Guidance
Record Full-Year Revenue Growth
Total revenue of $875.3M for FY2025, up 82.4% from $479.9M in FY2024, driven by hospital division expansion and stronger collections.
Significant Adjusted EBITDA and Profit Improvement
Adjusted EBITDA increased to $259.6M in 2025 (up 152.6% from $102.8M in 2024). Operating income rose to $275.6M (vs. $130.7M prior year) and net income attributable to Nutex was $70.8M (increase of $18.7M, ~36% YoY).
Very Strong Cash Generation and Liquidity
Net cash provided by operating activities was $248.1M for the 12 months ended 12/31/2025 (up $225.0M vs $23.2M prior year). Cash on hand grew to $185.6M as of 12/31/2025, up 356.6% from $40.6M a year earlier.
Volume Growth and High Patient Satisfaction
Total hospital visits increased to 188,279 in 2025, up 11.8% from 168,388 in 2024. Mature facilities grew 1.3% for the year. The company received >8,700 patient reviews averaging a 4.8/5 rating, indicating strong patient experience.
Margin and Cost Efficiency Gains
Gross profit improved to $444.3M (50.8% of revenue) vs $196.3M (40.9%) in 2024. Facility-level operating costs declined to 49.2% of revenue from 59.1% (nearly a 10 percentage-point improvement). Excluding arbitration expenses, operational costs were 33.4% of revenue in 2025 vs 47.1% in 2024.
Strategic Growth Initiatives and Capital Deployment
Opened 3 new hospitals (Sherman, TX; St. Louis, MO; Amble, TX) in 2025/early 2026, expanded profitable IPAs (~40,000 members) and launched a $25M share repurchase program (completed) with an additional $25M authorized, reflecting disciplined capital allocation.
NUTX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NUTX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 05, 2026 | $105.34 | $90.28 | -14.30% |
Nov 19, 2025 | $112.19 | $142.34 | +26.87% |
Nov 18, 2025 | $99.20 | $112.19 | +13.09% |
May 13, 2025 | $125.93 | $158.80 | +26.10% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Clinigence Holdings Inc (NUTX) report earnings?
Clinigence Holdings Inc (NUTX) is schdueled to report earning on May 19, 2026, TBA (Confirmed).
What is Clinigence Holdings Inc (NUTX) earnings time?
Clinigence Holdings Inc (NUTX) earnings time is at May 19, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NUTX EPS forecast?
NUTX EPS forecast for the fiscal quarter 2026 (Q1) is 3.99.